XML 54 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaborative Arrangement - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Sep. 23, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Carrying value $ 27,629,000 $ 27,629,000   $ 27,613,000  
Paid-in-kind interest   4,125,000 $ 798,000    
Sanofi-Aventis Deutschland GmbH | Mortgage Loan          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Carrying value 17,400,000 17,400,000      
License and Collaboration Agreement with Sanofi          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Maximum secured loan facility         $ 175,000,000
Senior notes, effective interest rate         8.50%
License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Maximum secured loan facility 175,000,000 175,000,000      
Carrying value 71,500,000 71,500,000      
Secured loan facility, amount borrowed   71,500,000      
Secured loan facility, amount earned 300,000        
Secured loan facility, amount owed $ 71,200,000 71,200,000      
Paid-in-kind interest   5,800,000      
License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH | Operating loss Sharing          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Company's total portion of loss sharing   $ 71,200,000